CinFina Pharma, a subsidiary of the hub-and-spoke biotech CinRx, shared early-stage data for two of its Janssen-licensed obesity candidates at this year’s ObesityWeek.
CIN-110, a PYY analog, and CIN-109, a growth differentiation factor 15 analog ...
↧